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The sugarcane pathogen Xanthomonas albilineans produces a family of antibiotics and phytotoxins termed
albicidins, which inhibit plant and bacterial DNA gyrase supercoiling activity, with a 50% inhibitory concen-
tration (50 nM) comparable to those of coumarins and quinolones. Here we show that X. albilineans has an
unusual, antibiotic-resistant DNA gyrase. The X. albilineans gyrA and gyrB genes are not clustered with
previously described albicidin biosynthesis and self-protection genes. The GyrA and GyrB products differ from
Escherichia coli homologues through several insertions and through changes in several amino acid residues
implicated in quinolone and coumarin resistance. Reconstituted X. albilineans DNA gyrase showed 20- to
25-fold-higher resistance than E. coli DNA gyrase to albicidin and ciprofloxacin and 8-fold-higher resistance
to novobiocin in the supercoiling assay. The X. albilineans DNA gyrase is unusual in showing a high degree of
distributive supercoiling and little DNA relaxation activity. X. albilineans GyrA (XaA) forms a functional gyrase
heterotetramer with E. coli GyrB (EcB) and can account for albicidin and quinolone resistance and low levels
of relaxation activity. XaB probably contributes to both coumarin resistance and the distributive supercoiling
pattern. Although XaB shows fewer apparent changes relative to EcB, the EcA  XaB hybrid relaxed DNA in
the presence or absence of ATP and was unable to supercoil. A fuller understanding of structural differences
between albicidin-sensitive and -resistant gyrases may provide new clues into features of the enzyme amenable
to interference by novel antibiotics.
DNA topoisomerases perform essential roles during the
processes of DNA transcription, replication, and recombina-
tion (1, 10, 40). Bacterial DNA gyrase has the unique ability to
introduce negative supercoils into DNA, an activity essential to
removal of excess positive supercoils generated when comple-
mentary strands are separated during replication of a circular
chromosome and to maintain a homeostatic level of negative
supercoiling to facilitate processes such as transcription. After
wrapping around the gyrase A2B2 protein complex, a DNA
loop is passed through a transient break in the bound DNA
backbone, which is then resealed, and the DNA is released
from the enzyme. This intramolecular strand passage results in
the introduction of two negative supercoils (10, 13). The GyrA
subunit is required for the bending, cleavage, and reunion of
DNA, and the GyrB subunit is required for the transduction of
energy from ATP binding and hydrolysis into the mechanism
for DNA strand passage. In vitro, the enzyme can work at
lower efficiency to relax supercoiled DNA without energy from
ATP.
Bacterial DNA topoisomerase IV in vivo is believed to per-
form intermolecular strand passage (decatenation) for the par-
titioning of replicated bacterial chromosomes (22) and to relax
excessive supercoiling from DNA gyrase action (43). Com-
posed of subunits encoded by parC and parE, which are ho-
mologous to gyrA and gyrB, it preferentially relaxes positive
supercoils and lacks supercoiling activity attributed to struc-
tural differences between the GyrA and ParC C-terminal
DNA-binding domains (13, 19, 34).
Bacterial DNA gyrase differs substantially from eukaryotic
topoisomerases and is the target of several classes of antibiot-
ics (26). The quinolones, including nalidixic acid and oxolinic
acid, and the peptide antibiotics microcin B17 and CcdB act by
interfering with the DNA-rejoining step. In contrast, the cou-
marins, including coumermycin A1 and novobiocin, compete
with ATP for binding to the GyrB subunit (26). Simocyclinones
inhibit an early step of the gyrase catalytic cycle by preventing
binding of the enzyme to DNA (15).
Albicidin antibiotics and phytotoxins from the sugarcane
pathogen Xanthomonas albilineans inhibit DNA replication in
bacteria and in sugarcane proplastids (4, 5). Albicidins cause
the characteristic chlorotic symptoms of sugarcane leaf scald
disease by blocking chloroplast development, and they play
additional roles in systemic disease establishment (2, 46). Al-
bicidins are potent inhibitors of the supercoiling activity of
bacterial and plant DNA gyrases, with a 50% inhibitory con-
centration (IC50) (40 to 50 nM) comparable to those of cou-
marins and quinolones but with some unique mechanistic ef-
fects (17). This prompted us to test whether X. albilineans has
an albicidin-resistant DNA gyrase in addition to previously
identified self-protection mechanisms of regulated biosynthesis
(44), efficient export (9), and a DNA-mimicking protein (17).
This paper describes the cloning and characterization of
gyrA and gyrB from X. albilineans and purification of the cor-
responding enzyme subunits. The reconstituted enzyme has
unusual functional properties, including multiple antibiotic re-
sistance, distributive supercoiling, and little relaxation activity
in vitro. By analysis of sequence features and hybrid enzymes,
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including X. albilineans and Escherichia coli subunits, we have
identified structural regions likely to contribute to these un-
usual functional properties of the X. albilineans DNA gyrase.
MATERIALS AND METHODS
Bacterial strains and culture conditions. Properties of bacteria and plasmids
used in this study are listed in Table 1. X. albilineans strains were routinely
cultured on sucrose peptone medium at 28°C (3). E. coli strains DH5 and
Top10 used as hosts in cloning experiments were grown on LB medium at 37°C
(35). Broth cultures were aerated by shaking at 200 rpm on an orbital shaker.
Growth of liquid cultures was measured by determining the optical density at 600
nm. The following antibiotics were added to media as required: kanamycin (50
g/ml); ampicillin (100 g/ml); and chloramphenicol (30 g/ml).
Routine genetic procedures. DNA isolation, restriction digestions, ligation
reactions, and transformation and electrophoresis of DNA and proteins were
performed as described by Sambrook et al. (35). High-fidelity Taq polymerase
(Invitrogen) with proofreading activity was used in all PCRs. DNA fragments
were excised from agarose gels, and residual agarose was removed using a
BresaClean DNA purification kit (GeneWorks, Adelaide, Australia).
Isolation and sequencing of gyrA and gyrB. Primers XalbgyrAfwd (5-ATG
GCA GAA ACC GCC AAG GAA ATC-3) and XalbgyrArev1 (5-TTG CCG
TTG CGC TCG GTG G-3) were designed based on the nucleotide sequences
of gyrA from Xanthomonas campestris (GenBank accession no. NP_636945.1)
and Xanthomonas axonopodis (NP_641963.1). Amplification of X. albilineans
gyrA was achieved with an initial denaturation at 94°C for 10 min followed by five
cycles of denaturation for 1 min at 94°C, 1 min of annealing at 50°C, and 2 min
of polymerase extension at 72°C, 25 cycles of 1 min of denaturation at 94°C, 1
min of annealing at 55°C, and 1 min of extension at 72°C, and then a final
extension for 10 min at 72°C followed by cooling to 4°C. The sequences for the
5 and 3 ends of the gene were obtained by sequencing directly from the
genomic DNA of X. albilineans by use of primers corresponding to the regions
inside the primers listed above. The X. albilineans gyrB gene was initially isolated
and sequenced during investigation of sequences flanking the Tn5 insertion in
leaky Tox-negative mutant LS135 (39).
Sequencing reactions were performed by dideoxynucleotide chain termination
(36) using a BigDye Terminator cycle sequencing kit and 373A DNA sequencer
(PE Applied Biosystems) available from the Australian Genome Research Fa-
cility. Oligonucleotide primers were purchased from GeneWorks (Adelaide,
Australia). DNA and protein sequences were compared in the GenBank, EMBL,
and Swiss-Prot databases (accession date, 3 Dec 2006). Molecular weights and
extinction coefficients for GyrA and GyrB were calculated using Vector NTi
version 9 (InforMax).
Construction of expression vectors for GyrA and GyrB. The coding regions of
gyrA and gyrB were amplified using PCR from genomic DNA of X. albilineans
strain LS155. Primer GyrA_fwd_2 (5-GAA CCC ATA TGG CAG AAA CCG
CCA AGG-3) contained an NdeI restriction site (underlined), whereas primer
GyrA_rev_XhoI (5-ATC AGC CCT CGA GCG ACG CGG TG-3) introduced
an XhoI site (underlined) overlapping the stop codon. The amplified gyrA was
digested using NdeI/XhoI and ligated into pET-29b to give pET-GyrA29b, which
resulted in a six-His tag at the carboxy terminal.
The coding region of gyrB was amplified using primers XagyrB_fwd (5-CCT
ACT GCG AGC CAT ATG ACC GAC GAA CAG-3) and XagyrB_rev
(5-AGA CAT GGC AAG GGA TCC GTC CCG GCA TAG-3) containing
restriction sites (underlined) and cloned into NdeI/BamHI sites of pET-19b to
yield pET-GyrB19b, introducing a deca-His tag at the amino terminal.
Purification of GyrA and GyrB subunits. E. coli BL21(DE3)pLysS carrying
pET-GyrA29b or pET-GyrB19b was grown at 37°C overnight in 20 ml of LB
medium containing 30 g/ml of chloramphenicol and 100 g/ml of ampicillin for
GyrB or 50 g/ml of kanamycin for GyrA. Bacteria were harvested by centrifu-
gation at 2,000  g for 10 min at room temperature. The pellet was suspended
in 20 ml of LB and used to inoculate 150 ml of LB containing the selective
antibiotics. Cells were grown at 30°C until the optical density at 600 nm reached
0.4 for GyrA and 0.6 for GyrB. IPTG (isopropyl--D-thiogalactopyranoside) was
added to reach a final concentration of 0.5 mM, and growth was continued for a
further 3 h. Bacterial cells were harvested by centrifugation at 6,000  g for 10
min at 4°C, and the pellet was suspended in 12 ml of binding buffer (20 mM
Tris-HCl [pH 7.9], 500 mM NaCl, and 5 mM imidazole). The cells were snap
frozen in liquid N2 and stored at 80°C until further use.
The suspension was thawed on ice, lysozyme was added to reach a final
concentration of 0.1%, and the mixture was incubated on ice for 30 min. The cells
were then disrupted by sonication on ice using a Branson 250 sonifier (using four
20-s bursts with a 30-s rest between cycles and a Microtip probe set to 50-w power
output) and centrifuged at 45,000  g for 20 min at 4°C. The supernatant was
mixed with 4 ml of 50% nickel-nitrilotriacetic acid resin (Qiagen) in a sterile
precooled tube and gently agitated at 4°C for 1 h. The suspension was centri-
fuged at 700  g for 2 min at 4°C and washed with 30 ml of binding buffer and
then four times with 30 ml of wash buffer (20 mM Tris-HCl [pH 7.9], 500 mM
NaCl, and 60 mM imidazole). The washed resin was then resuspended in 2 ml of
elution buffer (20 mM Tris-HCl [pH 7.9], 500 mM NaCl, and 250 mM imidazole),
and the His-tagged proteins were eluted through a filtration column. The eluted
proteins were dialyzed at 4°C overnight in 2.5 liters of 50 mM Tris-HCl (pH 7.9),
30% glycerol, 1 mM dithiothreitol (DTT),and 1 mM EDTA. The dialyzed pro-
teins were flash frozen in liquid N2 and stored at 80°C. Protein purity was
assessed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis.
Protein concentrations were quantified using a spectrophotometer (Nanodrop
ND-1000) at 280 nm.
DNA gyrase assays. Supercoiling activity was tested using various ratios of
purified X. albilineans DNA gyrase A and B subunits. E. coli DNA gyrase
(Inspiralis Ltd., Norwich, United Kingdom) was used as a positive control.
TABLE 1. Properties of strains and plasmids
Strain or plasmid Relevant characteristic(s)a Reference or source
Strains
E. coli
DH5a 	80dlacZ
M15, 
(lacZYA–argF)U169 Promega
BL21 (DE3)pLysS Invitrogen
KNK546 F polA thyA uvrA phx gyrA43 (Ts) 24
N4177 strA galK gyrB221 (Cour) gyrB203 (Ts); Cour mutation (Arg136Cys); Ts
mutation (Pro171Ser)
27
TOP10 F 
(mrr–hsdRMS–mcrBC) 
(are–leu)7697 
lacX74 Invitrogen
X. albilineans
Xa13 Wild-type albicidin producer from sugarcane (Queensland, Australia); Apr 44
LS135 Albicidin-leaky mutant of LS155 39
LS155 Wild-type albicidin producer from sugarcane (Queensland, Australia); Apr 39
Plasmids
pBluescript II Expression vector; native protein; bla (Apr) Stratagene
pET-19b Expression vector; His10 fusion protein (N terminal); bla (Ap
r) Invitrogen
pET-GyrB19b pET-19b containing gyrB; Apr This study
pET-29b Expression vector; His6 fusion protein (C terminal); bla (Km
r) Invitrogen
pET-GyrA29b pET-29b containing gyrA; Apr This study
pBR322 Substrate DNA for DNA gyrase assays 8
a Ts, temperature sensitive; Cou, coumermycin; Ap, ampicillin; Km, kanamycin.
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FIG. 1. Comparison of the amino acid sequences of the DNA gyrase A subunits from E. coli (Ec; GenBank accession no. NP_754659.1), X.
albilineans (Xa; this study), X. axonopodis (Xax; NP_636945.1), and X. campestris (Xc; NP_636945.1). Identical amino acids are represented by
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Compatibility of X. albilineans and E. coli DNA gyrase subunits was tested at
various ratios. The methanol concentration in reactions testing albicidin sensi-
tivity was constant at 1.25% (vol/vol).
Gyrase supercoiling reaction mixtures (30 l) containing gyrase (1 U), buffer
(35 mM Tris-HCl [pH 7.5], 24 mM KCl, 4 mM MgCl2, 2 mM DTT, 1.8 mM
spermidine, 1 mM ATP, 6.5% [wt/vol] glycerol, 0.1 mg/ml bovine serum albu-
min), and 5 nM (0.4 g) of relaxed pBR322 DNA were incubated at 37°C for 30
min and then terminated by addition of a 0.5 volume of STEB (20% [wt/vol]
sucrose, 0.05 M Tris-HCl [pH 7.5], 0.05 M EDTA, 50 g/ml bromophenol blue)
and 2 volumes of chloroform-isoamyl alcohol (24:1) followed by electrophoretic
analysis in 1% agarose gels. Gyrase relaxation assays were performed similarly to
the supercoiling assays except that ATP and spermidine were omitted and the
substrate was supercoiled pBR322 DNA. Gels were viewed and photographed on
a GelDoc system (Bio-Rad) using autoexposure. Intensities of bands were cal-
culated using one-dimensional Totallab TL100 gel analysis software (version
2006b; Nonlinear Dynamics). GraphPad Prism (version 4.0) was used to analyze
the data and determine IC50 values using a one-phase exponential decay curve.
DNA cleavage reactions contained gyrase (2 U), 5 to 12 nM relaxed pBR322
DNA, 35 mM Tris-HCl (pH 7.5), 24 mM KCl, 4 mM MgCl2, 2 mM DTT, 1.8 mM
spermidine, 0.1 mg/ml bovine serum albumin, 6.5% (wt/vol) glycerol, and various
concentrations of drug in the presence of 1 mM ATP. Linear product was
released by the addition of SDS to 0.2% (wt/vol) and proteinase K to 0.1 mg/ml
followed by incubation at 37°C for 30 min. Samples were analyzed by electro-
phoresis in 1% agarose (in the presence of 1 g/ml of ethidium bromide).
Preparation of albicidin and assay of albicidin resistance. Albicidin was pre-
pared from X. albilineans Xa13 and quantified as described previously (3). The
HPLC-purified  peak of albicidin was used in all assays. Albicidin resistance was
quantified by a microbial plate bioassay as described previously (45).
Nucleotide sequence accession numbers. The full-length sequences of X.
albilineans gyrA and gyrB obtained in this study have been deposited in GenBank
under accession no. EU267170 and EU267171, respectively.
RESULTS
Cloning and sequencing of the gyrA and gyrB genes from X.
albilineans. Attempts to clone the full-length X. albilineans gyrA
in pBlueScript II were unsuccessful. DNA supercoiling in E.
coli is controlled by a homeostatic mechanism (27), and over-
expression of the introduced gyrA probably inhibited growth
through a compositional imbalance of gyrase subunits or ex-
cessive DNA supercoiling. To overcome this, gyrA was cloned
behind the T7 promoter in pET-19b (only induced in strains
carrying the T7 polymerase gene).
The full-length gyrB gene was contained along with a Tn5
insertion in a 2.7-kb EcoRI fragment cloned from X. albilin-
eans Tox-negative leaky mutant LS135 into pBluescript II.
Bioinformatic analysis of gyrA and gyrB. Analysis of the
cloned gyrA sequence revealed an open reading frame of 2,805
bp encoding a 935-amino-acid protein with an Mr of 102,840
(Fig. 1). The deduced amino acid sequence showed highest
(83%) identity to that of the DNA GyrA subunit of X. campes-
tris (GenBank accession no. NP_636945.1) and X. axonopodis
(NP_641963.1). It showed 62% identity to that of the E. coli
DNA GyrA subunit (NP_754659.1) (Fig. 1).
A FASTA search of the Swiss-Prot database was performed
to select the 21 most similar proteins (GyrA and ParC) for
construction of a protein tree revealing GyrA and ParC groups
(data not shown). The identities between X. albilineans GyrA
and other GyrA proteins ranged from 58% to 83%, while
identities with ParC were below 35%. As expected, the
X. albilineans GyrA clustered closely with X. campestris, X.
axonopodis, and X. oryzae GyrA proteins.
The X. albilineans gyrB open reading frame encodes a pro-
tein of 820 amino acids, with an Mr of 90,230 (Fig. 2) and 60 to
61% identity to the GyrB subunits from E. coli (GenBank
accession no. G41646), Salmonella enterica serovar Typhi-
murium (GenBank accession no. Q60008), Haemophilus influ-
enzae (GenBank accession no. G1573554), and Pseudomonas
putida (GenBank accession no. G45694).
The promoter regions of gyr genes typically play a role in
relaxation-stimulated transcription to regulate cellular DNA
topology, and the mechanism appears to involve a propensity
to curvature in the vicinity of the 10 region rather than any
particular consensus sequence (38). In X. albilineans, se-
quences similar to the “extended 10” bacterial consensus
promoter sequence (TGNTATAAT) (23) exist 78 bp upstream
of the translational start of the gyrB gene and 109 bp upstream
of the start of gyrA. Both promoters lack canonical35 regions
(TTGACA). The E. coli gyrA promoter similarly shows an
extended 10 region without a canonical 35 region (25). In
E. coli, the RNA polymerase sigma 70 subunit recognizes the
10 extended region, in which the TG motif plays a role in
efficient initiation without a canonical 35 region (7, 23).
Purification of X. albilineans gyrase subunits. Expression of
X. albilineans gyrA and gyrB in E. coli pET expression vectors
and purification from 150 ml of IPTG-induced cell culture by
nickel chelate chromatography yielded 1 mg and 3 mg of His-
tagged proteins, respectively. SDS-polyacrylamide gel electro-
phoresis analysis of the gyrase subunits showed that GyrA and
GyrB have the expected molecular weights of 102,000 and
90,000, respectively (data not shown).
Supercoiling activity of X. albilineans DNA gyrase. Combi-
nations of GyrA and GyrB proteins were tested for DNA
supercoiling activity in the presence or absence of 1 mM ATP
by use of relaxed pBR322 as the substrate (Fig. 3). Gyrase
subunits were reconstituted at A:B molar ratios of 80:20, 20:80,
and 50:50 and were then titrated to determine the minimum
for 50% supercoiling of 0.4 g of relaxed pBR322 within 30
min in the routine assay conditions. This was designated 1 U of
DNA gyrase activity. Neither subunit alone could supercoil
relaxed substrate. A 20:80 ratio of the A and B subunits gave
optimal supercoiling activity. All tested subunit ratios resulted
in multiple DNA products of intermediate topology revealed
as bands which migrate more slowly than the main, highly
supercoiled product. No supercoiling was observed in the ab-
sence of ATP (Fig. 3).
Susceptibility of X. albilineans DNA gyrase to albicidin, cip-
rofloxacin, and novobiocin. In the DNA supercoiling assay,
compared to the E. coli enzyme results, the X. albilineans
gyrase gave IC50 values 25-fold higher for albicidin and cipro-
floxacin and 8-fold higher for novobiocin (Fig. 4 and Table 2).
In the assay for DNA cleavage induced by antibiotic in the
black characters on a gray background. Residues in E. coli GyrA that form the active site of the breakage-reunion reaction, including the Tyr-122
residue that covalently binds the DNA, are indicated by arrows (2). Residues involved in quinolone resistance are indicated by filled circles (●).
Residues involved in CcdB resistance in E. coli are indicated by filled inverted triangles (). Bold letters with a five-pointed star above indicate
amino acids uniquely variant in X. albilineans from known GyrA amino acids (Swiss-Prot; accession date, 2 December 2006).
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presence of DNA gyrase, the X. albilineans enzyme gave CC50
values at least 4-fold higher for albicidin and at least 10-fold
higher for ciprofloxacin compared to the E. coli enzyme values
(Fig. 5). We use CC50 to mean the antibiotic concentration
required to obtain half of the maximum yield of linear DNA
observed in the reaction mixture containing antibiotic, gyrase,
ATP, and DNA.
Compatibility of X. albilineans and E. coli DNA gyrase
subunits. The combination of X. albilineans GyrA with E.
coli GyrB formed a functional DNA gyrase (designated
FIG. 2. Comparison of the amino acid sequences of the DNA gyrase B subunits from E. coli (Ec; GenBank accession no. G41646), X. albilineans
(Xa; this study), X. axonopodis (Xax; NP_640360), and X. campestris (Xc; YP_241118). Identical amino acids are represented by black characters
on a gray background. Residues important in ATP binding and hydrolysis in E. coli are indicated by arrows (2). The two residues known to confer
resistance to coumarin in E. coli are indicated by filled inverted triangles (). The two residues shown to be involved in quinolone resistance in
E. coli are indicated by a filled circle (●). The residue conferring resistance to microcin A17 in E. coli is indicated by a five-pointed star.
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XaA  EcB) with an IC50 in the supercoiling assay of 1,500,
7,500, and 100 nM for albicidin, ciprofloxacin, and novobio-
cin, respectively, close to the results obtained with XaAB for
albicidin and ciprofloxacin and with EcAB for novobiocin
(Fig. 4 and Table 2).
Unexpectedly, the X. albilineans DNA gyrase and the
XaA  EcB hybrid enzyme were unable to relax supercoiled
pBR322 even at 10 times the XaA  EcB enzyme concentration
that proved effective in the supercoiling assay (Fig. 6A and B).
In contrast, the EcA  XaB combination was nonfunctional for
supercoiling, but it could relax supercoiled pBR322 in both the
presence and the absence of ATP (Fig. 6A). This relaxation
activity by the EcA  XaB enzyme was as sensitive as that of the
wild-type E. coli DNA gyrase was to ciprofloxacin (Fig. 6C).
Combining the in vitro results with those revealing the ear-
lier cloning effects shows that toxicity resulted from overex-
pression in E. coli of a heterologous subunit capable of
reconstituting a DNA gyrase functional for supercoiling
(XaA  EcB) but that overexpression of a subunit that does not
form a hybrid capable of supercoiling (EcA  XaB) did not
result in toxicity.
DISCUSSION
Purified, reconstituted X. albilineans DNA gyrase has high
specific activity for supercoiling. The use of His tags facilitated
purification of X. albilineans DNA gyrase subunits free from
host (E. coli) proteins. The specific activity of reconstituted X.
albilineans DNA gyrase for supercoiling was 12,500 U/mg. Dif-
ferent studies have reported comparable specific activities of
native DNA gyrases from E. coli (11,500 U/mg), Micrococcus
luteus (20,000 U/mg), Vibrio cholerae (28,369 U/mg), and Ba-
cillus subtilis (10,000 U/mg) (32, 37, 47). Based on the optimal
molar ratio of 20 A:80 B for reconstituted activity, heterolo-
gous expression of gyrB may yield a higher proportion of mis-
folded subunits. A higher specific activity of purified GyrA
relative to that of GyrB has also been also reported from
studies of E. coli (29). Native and His6-tagged DNA gyrase
subunits from E. coli have shown equivalent levels of activity in
ATPase, DNA supercoiling, and DNA relaxation assays (16).
Therefore, the His-tagged X. albilineans proteins were used in
all subsequent assays.
X. albilineans DNA gyrase shows unusually distributive su-
percoiling. DNA gyrases are typically highly processive, be-
cause the enzyme binds stably at the cleavage site on relaxed
DNA and performs rapid supercoiling in the presence of ATP
followed by rapid release of the enzyme from the supercoiled
product (31). In routine supercoiling assays, this yields a single
band in the supercoiled product region, as shown for the E. coli
enzyme in Fig. 3 and Fig. 4.
In contrast, the X. albilineans DNA gyrase showed more
distributive supercoiling, with multiple DNA bands near the
main supercoiled form indicating dissociation of the enzyme
from the bound DNA molecule at intermediate supercoil den-
sities. Distributive supercoiling has been reported in studies of
E. coli DNA gyrase variants, for example, the N-terminal 64-
FIG. 3. Supercoiling activity of X. albilineans and E. coli DNA
gyrase A and B subunits. Relaxed pBR322 (0.4 g) was incubated with
DNA GyrA of GyrB or a mixture of the two in the presence () or
absence () of ATP (1 mM). Lanes: M, DNA/HindIII; P, no DNA
gyrase; XaA, X. albilineans DNA gyrase A; XaB, X. albilineans DNA
gyrase B; XaAB and EcAB, reconstituted DNA gyrases (1 U each) of
X. albilineans and E. coli, respectively. R and S, relaxed and super-
coiled DNA, respectively.
FIG. 4. Supercoiling activity of X. albilineans (XaAB), E. coli
(EcAB), and hybrid (XaA  EcB) DNA gyrases in the presence of
albicidin (A), ciprofloxacin (B), and novobiocin (C). Relaxed pBR322
(0.4 g) was incubated with DNA gyrase in the presence of 1 mM
ATP. R and S, relaxed and supercoiled pBR322, respectively.
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kDa fragment of GyrA reconstituted with intact GyrB (33) and
the GyrB K447E mutant which confers quinolone resistance at
the expense of an 80% reduction in supercoiling specific activ-
ity (18). The mechanistic relationship between antibiotic resis-
tance and the unusual combination of distributive supercoiling
with high specific activity in the X. albilineans DNA gyrase
remains to be determined. However, it is interesting that the
XaA  EcB hybrid showed processive supercoiling (Fig. 4).
Multiple sequence changes potentially implicated in antibi-
otic resistance of X. albilineans DNA gyrase. The residues that
form the active site of the breakage-reunion N-terminal do-
main of GyrA in E. coli as revealed by the crystal structure (30)
are conserved in the X. albilineans GyrA (Fig. 1). However, the
X. albilineans protein has two insertions, of 29 and 43 amino
acids, in the C-terminal-region, which is involved in DNA
wrapping and complex stability. The larger insertion is unique
to the X. albilineans GyrA, and the shorter insertion is con-
served in position but divergent in sequence in other Xan-
thomonas spp. Both are rich in negatively charged residues.
The crystal structure of the C-terminal domain of GyrA
from E. coli revealed a -pinwheel fold with six propeller
blades. The electropositive band around the perimeter of the
pinwheel structure, at the outer edges of blades 4, 5, 6, and 1,
is believed to be important in bending DNA into the required
loop for negative supercoiling (13, 34). Therefore, it is inter-
esting to see from alignment of the X. albilineans and E. coli
domains that the two electronegative insertions in X. albilin-
eans GyrA lie within loops that connect the fourth blade to the
third and fifth blades, where they may modify this charged
band. R691 is also interesting in this context because in E. coli
GyrA, the corresponding residue D692, along with other con-
served residues in the third propeller blade, has been shown to
be important for DNA binding, supercoiling, and relaxation
activities (20). These unusual electrochemical features of the
X. albilineans GyrA do not cause distributive activity, as
XaA  EcB is processive. However, they may be associated
FIG. 5. Albicidin- and ciprofloxacin-induced DNA cleavage by X.
albilineans (XaAB) and E. coli (EcAB) DNA gyrase. Relaxed pBR322
(0.4 g) was used as a substrate in the presence of 1 mM ATP, 2 U
DNA gyrase, and the indicated concentration of albicidin or cipro-
floxacin. R and S, relaxed and supercoiled pBR322, respectively. L,
linear pBR322.
TABLE 2. Sensitivity of supercoiling activity of reconstituted DNA
gyrases to antibiotics
Drug
IC50 (nM) for indicated reconstituted DNA gyrase(s)a
XaAB EcAB XaA  EcB
Albicidin 1,350 50 1,500
Ciprofloxacin 7,500 300 7,500
Novobiocin 800 100 100
a A, GyrA; B, GyrB; Xa, X. albilineans; Ec, E. coli.
FIG. 6. Relaxation activities of X. albilineans, E. coli, or hybrid
DNA gyrases. (A) Supercoiled pBR322 was incubated with DNA
GyrA or GyrB or a mixture of the two in the presence () or absence
() of ATP (1 mM). (B) Repeat supercoiling assay in the absence of
ATP. Lanes: S, supercoiled pBR322; EcA, E. coli GyrA; EcB, E. coli
GyrB; XaA  EcB, X. albilineans GyrB and E. coli GyrA; EcA  XaB,
E. coli GyrA and X. albilineans GyrB; Ec AB, E. coli GyrA and GyrB;
XaAB, X. albilineans GyrA and GyrB. R and S, relaxed and super-
coiled DNA, respectively. (C) Sensitivity of the hybrid EcA  XaB and
E. coli DNA gyrase to ciprofloxacin and albicidin. R and S, relaxed
and supercoiled DNA, respectively. EcA  XaB, E. coli GyrA and X.
albilineans GyrB; EcAB, E. coli GyrA and GyrB.
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with the inability to relax supercoiled DNA, as discussed be-
low.
Q83 is interesting because in E. coli, GyrA mutations S83L,
S83W, and S83A confer 5- to 10-fold-increased quinolone re-
sistance (11, 28) and S83W increases albicidin resistance by 4
to 6-fold (17). The X. albilineans GyrA has two other residues
(T455 and Y664) that are uniquely variant from all other
sequenced GyrA enzymes, but residues at these positions are
not highly conserved and have not been previously implicated
in gyrase function or antibiotic resistance.
The X. albilineans GyrB sequence includes the 12 residues
important in ATP binding and hydrolysis, as revealed by the
crystal structure of E. coli GyrB (41), and with two exceptions,
it matches the E. coli sequence at residues implicated in anti-
biotic sensitivity. In E. coli GyrB, K447E confers quinolone
resistance at the expense of an 80% reduction in supercoiling
specific activity (18). The corresponding residue in X. albilin-
eans GyrB is R463 (Fig. 2). In E. coli GyrB, R136C, R136H,
R136L, R136A, and R136S confer resistance to coumarins (12,
14). The corresponding residue in X. albilineans GyrB is Q151.
Although X. albilineans is susceptible to coumarins in vivo, the
purified DNA gyrase from X. albilineans shows eightfold-
higher resistance than the E. coli enzyme to novobiocin (Table
2). The six-amino-acid insertion in the N-terminal region
(ATPase domain) of the X. albilineans GyrB (Fig. 2) may also
be relevant in this context. A similar insertion exists in the
same region in 10 sequenced GyrBs from Chlamydia spp., but
the effect on coumarin sensitivity has not been reported.
Taken together, these considerations pointed toward an in-
teraction between multiple sequence changes, most likely in-
cluding GyrB Q151, GyrB R451, GyrA Q83, and the unusual
insertion in the C-terminal region of the A subunit, resulting in
a DNA gyrase conformation in X. albilineans that is less sus-
ceptible than its E. coli homologue to diverse antibiotics. The
ability to reconstitute functional DNA gyrase in vitro by mixing
the purified subunits provided an opportunity to resolve some
of these contributions.
The X. albilineans GyrA subunit confers albicidin resistance.
The GyrA subunit from X. albilineans was compatible with
GyrB from E. coli. The hybrid enzyme (XaA  EcB) equaled
the X. albilineans holoenzyme (XaAB) in resistance to albici-
din and ciprofloxacin, in contrast to the sensitivity of the E. coli
holoenzyme (EcAB) (Table 2). Therefore, differences in the A
subunit alone can account for the observed levels of albicidin
and ciprofloxacin resistance, implying that the A subunit is the
albicidin target. The molecular target was not resolved to this
level in previous studies using E. coli mutants, because albici-
din-resistance mutations in E. coli map to the tsx locus and
block antibiotic uptake (6, 17).
The X. albilineans GyrA subunit is associated with an inabil-
ity to relax supercoiled DNA. Although relaxation of super-
coiled DNA is energetically favorable and although this reac-
tion by DNA gyrase is ATP independent, it is less efficient than
ATP-dependent supercoiling, as evidenced by the higher en-
zyme concentrations required for relaxation assays (29). The
mechanisms for the operation of the three gates in DNA
gyrase during “reverse”-strand passage for relaxation are less
well understood than those involving ATP for “forward”-
strand passage during supercoiling (42).
The unexpected absence of detectable relaxation by the X.
albilineans gyrase or the XaA  EcB hybrid may indicate a
“tighter” gate which torsional energy in the supercoiled DNA
is insufficient to operate. The evidence indicates that the dif-
ference arises as a result of the presence of the X. albilineans A
subunit, which imparts local superhelicity to the looped DNA,
contributes to the DNA cleavage gate, and forms the exit gate
(in the supercoiling context).
The reciprocal hybrid (EcA  XaB) was not functional for
supercoiling, but it was capable of relaxation in both the pres-
ence and the absence of ATP. Therefore, the EcA  XaB hy-
brid associates well enough for strand cleavage and “reverse”-
strand passage through the three functional gates but evidently
not well enough for complete transduction of the ATP-medi-
ated conformational changes needed for supercoiling. The re-
laxation activity of the EcA  XaB enzyme was as sensitive as
that of the E. coli holoenzyme to the presence of ciprofloxacin,
which is consistent with the identification of the A subunit as
the major determinant of this sensitivity.
Implications for development of new antibiotics and dis-
ease-resistant sugarcane. Because DNA gyrase is essential to
prokaryotes, it is an appealing target for antibiotic develop-
ment. Quinolones are the only commercially available phar-
maceuticals that target DNA gyrase. However, resistance to
quinolones resulting from single-base mutations in DNA gy-
rase genes has been documented for several clinically impor-
tant pathogens. We have previously shown that albicidin is a
potent inhibitor of DNA gyrase, with the unusual property of
rapid, ATP-dependent stabilization of the gyrase-DNA cleav-
age complex (17). Here we show that the X. albilineans gyrase
has multiple unique residues that, in combination, confer an
unusual set of topoisomerase activities along with high-level
resistance to diverse antibiotics. A deeper understanding of the
unusual molecular interactions between albicidin and DNA
gyrase may assist the effort to develop antibacterial agents that
are more potent and last longer.
Albicidins are pathogenesis factors in sugarcane leaf scald
disease, and albicidin resistance may be engineered to confer
disease resistance (2, 46). Antibiotic resistance mediated by
mutation in DNA gyrase is typically recessive (21) and there-
fore is probably not useful in efforts to devise a strategy for
engineering a polyploid plant such as sugarcane. However, as
in the albicidin-producing organism, it may be useful in plants
to combine several mechanisms, such as a DNA-mimicking
protein (17) along with an enzyme for albicidin detoxification
(46), to obtain better protection against the disease.
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